期刊文献+

安慰剂镇痛效应的个体差异及其影响因素 被引量:2

Individual Differences in Placebo Analgesia: Contributions of Psychological and Neurobiological Factors
原文传递
导出
摘要 安慰剂在随机临床试验中有着悠久而重要的作用,主要用于控制考察药物的真实疗效。而近几十年来,安慰剂本身作为一种典型的"身心交互"模型,得到了更多的关注。对安慰剂作用机制的研究也有助于揭示心理因素影响临床结果的本质。然而安慰剂效应在不同的个体中有较大的差异。本文试综述在疼痛领域与安慰剂个体差异相关的文献,并总结影响该差异的各种因素。同时提出目前研究中存在的问题及今后的研究方向。 Placebos are traditionally used as controls in clinical trials to measure the specific effect of certain therapeutic treatment. More recently, placebo analgesia has attacted more attention as a research paradigm for mind-body interaction. Previous studies have demonstrated placebo effects depend on conscious expectancy or learning mechanisms such as conditioning. However, individual response to placebo analgesic effect ranges from no effect(non-responders) to complete pain relief(responders). The mechanisms underlying this inter-individual differences of placebo responses are poorly understood. Convincing evidence support that efficiency of endogenous receptors, brain activity, and genetic factors may contribute to the individual differences of placebo responses.
出处 《中国临床心理学杂志》 CSSCI CSCD 北大核心 2014年第6期994-998,993,共6页 Chinese Journal of Clinical Psychology
基金 国家自然科学基金(30800301 31170992 31371038)
关键词 安慰剂 镇痛 个体 Placebos Analgesia Individual Differences
  • 相关文献

参考文献55

  • 1De La Fuente-Fernandez R, Stoessl AJ. The placebo effect in Parkinson' s disease. Trends in Neurosciences, 2002, 25 (6): 302-306.
  • 2Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annual Review ofPharmacology and Toxicology, 2008, 48:33-60.
  • 3Finniss DG, Kaptchuk TJ, Miller F, et al. Biological, clini- cal, and ethical advances of placebo effects. The Lancet, 2010, 375(9715): 686-695.
  • 4Nemoto H, Nemoto Y, Toda H, et ah Placebo analgesia: a PET study. Experimental Brain Research, 2007, 179(4): 655-664.
  • 5Hr6bjartsson A, Gctzsche PC. Is the placebo powerless? An analysis of clinical trims comparing placebo with no treat- ment. New England Journal of Medicine, 2001, 344(21): 1594-1602.
  • 6Vase L, Riley III JL, Price DD. A comparison of placebo eff- ects in clinical analgesic trials versus studies of placebo an- algesia. Pain, 2002, 99(3): 443-452.
  • 7Murray D, Stoessl AJ. Mechanisms and therapeutic implica- tions of the placebo effect in neurological and psychiatric conditions. Pharmacology and Therapeutics, 2013, 140(3): 306-318.
  • 8De la Fuente-Femrndez R, Ruth TJ, Sossi V, et al. Expect- ation and dopamine release: mechanism of the placebo effect in Parkinson' s disease. Science, 2001, 293(5532): 1164- 1166.
  • 9Price DD, Milling LS, Kirsch I, et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain, 1999, 83(2): 147-156.
  • 10Vase L, Petersen GL, Riley III JL, et al. Factors contributing to large analgesic effects in placebo mechanism studies con- ducted between 2002 and 2007. Pain, 2009, 145(1): 36-44.

二级参考文献13

  • 1Turk DC, Wilson HD. Fear of pain as a prognostic factor in chronic pain: Conceptual models, assessment, and treatment implications. Current Pain and Headache Reports, 2010, 14: 88-95.
  • 2Vlaeyen JW, linton S1. Fear-avoidance and its consequ?ences in chronic musculoskeletal pain: A state of the art. Pain, 2000, 85:317-332.
  • 3Asmundson GJG, Norton PJ, Vlaeyen JWS. Fear-avoidance models of chronic pain: An overview, in Asmundson GJG, Vlaeyen JWS, Crombez G: Understanding and Treating Fear of Pain, 2004. 3-24.
  • 4Leeuw M, Goossens ME, Linton SJ, et al. The fear-avoid?ance model of musculoskeletal pain: Current state of scien?tific evidence. J Behav Med, 2007, 30: 77-94.
  • 5Crombez G, Vlaeyen JW, Heuts PH, et al. Pain-related fear is more disabling than pain itself: Evidence on the role of pain -related fear in chronic back pain disability. Pain, 1999, 80: 329-339.
  • 6McNeil DiW, Rainwater AJ. Development of the fear of pain questionnaire-III. Journal of Behavioral Medicine, 1998,21: 389-410.
  • 7Wong WS, McCracken LM, Fielding R. Factor structure and psychometric properties of the Chinese version of the 20- item pain anxiety symptoms scale (ChPASS-20). Journal of Pain and Symptom Management, 2012, 43: 1131-1140.
  • 8Wong WS, McCracken LM, Fielding R. Factorial validity and reliability of the Chinese version of the pain vigilance and aqwareness questionnaire (ChPV AQ) in a sample of Chinese patients with chronic pain. Pain Medicine, 2011, 12: 1018-1025.
  • 9Yap JC, Lau J, Chen PP, et al. Validation of the Chinese pain catastrophizing scale(HK-PCS) in patients with chro?nic pain. Pain Medicine, 2008, 9: 186-195.
  • 10Osman A, Breitenstein JL, Barrios FX, et al. The fear of pain questionnaire-III: Further reliability and validity with nonclinical samples. Journal of Behavioral Medicine, 2002, 25: 155-173.

共引文献16

同被引文献9

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部